Tapentadol Hydrochloride API: Injectable & Micronized Dual-Action Analgesic

Tapentadol Hydrochloride is a centrally acting analgesic representing a new pharmacological class. It provides a synergistic effect by combining Mu-opioid receptor agonism with Norepinephrine Reuptake Inhibition (NRI). This dual mechanism makes it exceptionally effective for managing both acute nociceptive pain and chronic neuropathic pain, such as diabetic peripheral neuropathy, with a improved gastrointestinal tolerability profile compared to traditional opioids.

At Micro Orgo Chem (MOC), we manufacture Tapentadol HCl in our GMP certified facility. We specialize in Micronized Grades with a Particle Size Distribution (PSD) optimized for controlled-release (ER) and immediate-release (IR) oral dosage forms. We also offer a validated Injectable Grade processed under strict aseptic conditions, featuring controlled Bacterial Endotoxin (BET) levels for specialized clinical research.

Our API is compliant with USP and IP pharmacopeias, supported by comprehensive impurity profiling and stability data.